CAS 1356847-30-7

5-Methyl-L-Norleucine Orlistat Analogue

CAS : 1356847-30-7

Formule : C₃₀H₅₅NO₅

Couleur et forme : Orange Solid

Masse moléculaire : 509.78

Ref: 4Z-O-01822

5-Methyl-L-norleucine Orlistat Analogue

Produit contrôlé

CAS : 1356847-30-7

Formule : C₃₀H₅₅NO₅

Couleur et forme : Neat

Masse moléculaire : 509.761

Ref: TR-M320550

5-Methyl-L-norleucine orlistat analogue

CAS : 1356847-30-7

5-Methyl-L-norleucine orlistat analogue is an anticancer compound that acts as a kinase inhibitor. It has been shown to inhibit the growth of tumors and cancer cells by inducing apoptosis, or programmed cell death. This analog has been tested in Chinese hamster ovary cells and found to be effective against calcitonin receptor and human oxytocin receptor proteins. Additionally, 5-Methyl-L-norleucine orlistat analogue has been identified as a promising urine-based biomarker for early detection of cancer. Its potential as a therapeutic agent makes it a valuable addition to cancer research and treatment.

Formule : C₃₀H₅₅NO₅

Degré de pureté : Min. 95%

Masse moléculaire : 509.8 g/mol

Ref: 3D-GEC84730

5-Methyl-L-Norleucine Orlistat Analogue

CAS : 1356847-30-7

Formule : C₃₀H₅₅NO₅

Masse moléculaire : 509.78

Ref: ST-EA-CP-O11052